Imaging of metabolic bone disease by M. Mattera et al.
Imaging of metabolic bone disease 
Maria Mattera1, Alfonso Reginelli2, Silvia Bartollino3, Claudio Russo3, Antonio Barile4, 
Domenico Albano5, Giovanni Mauri6, Carmelo Messina7, Salvatore Cappabianca2,  
Giuseppe Guglielmi1, 8
1 Department of Radiology, University of Foggia, Foggia, Italy; 2 Department of Internal and Experimental Medicine, University 
of  Campania “Luigi Vanvitelli”, Naples, Italy; 3 Department of Medicine and Health Science “V. Tiberio”, University of  Moli-
se, Campobasso, Italy; 4 Department of Biotechnology and Applied Clinical Science, University of L’Aquila, Italy; 5 Department 
of Radiology, DIBIMED, University of Palermo, Palermo, Italy; 6 Division of Interventional Radiology, Istituto Europeo di 
Oncologia, Milano, Italy; 7Scuola di Specializzazione in Radiodiagnostica and Department of Biomedical Sciences for Health, 
Università degli Studi di Milano, Milano, Italy; 8 Department of Radiology, Scientific Institute “Casa Sollievo della Sofferenza” 
Hospital, San Giovanni Rotondo, Foggia, Italy
Summary. Osteoporosis is the most important metabolic bone disease, with a wide distribution among the 
elderly. It is characterized by low bone mass and micro architectural deterioration of bone tissue, leading to 
enhanced bone fragility and a consequent increase in fracture risk. Identify bone weakening with an appropri-
ate and accurate use of diagnostic imaging is of critical importance in the diagnosis and follow-up of osteo-
porotic patients. The aim of this review is to evaluate the detection rates of the different imaging modalities in 
the evaluation of bone strength, in the assessment of fracture risk and in the management of fragility fractures. 
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Introduction
Osteoporosis is recognized as a serious and in-
creasingly public health issue due to its high preva-
lence in aging people, in which it contribute to reduce 
physical performance and increase the risk of fall-re-
lated injury, disability, and mortality (1-5). 
Osteoporosis is the most important metabolic 
bone disease and is characterized by low bone mass 
and microarchitecture deterioration of bone tissue, 
leading to enhanced bone fragility and a consequent 
increase in fracture risk (6-10).
The most common type of osteoporosis is invo-
lutional osteoporosis, which is classified into type I or 
postmenopausal osteoporosis and type II or senile os-
teoporosis (11-20). Postmenopausal osteoporosis usu-
ally occurs in women between ages 50 and 65 years, 
affecting those within 15 to 20 years of menopause. 
The estrogenic deficiency is linked to an accelerated 
trabecular bone resorption, which may lead to fragility 
fractures that typically involve spine and wrist. Senile 
osteoporosis occurs in women or men more than 70 
years of age and the main feature is that the bone loss 
pattern involves the cortex and the trabeculae, leading 
to fragility fractures usually located at the hip, pelvis, 
and proximal humerus. Despite the well-recognized 
role of estrogenic deficiency in type I osteoporosis and 
the consequent higher prevalence of fragility fractures 
in 40-50 y.o. women, multiple investigations have con-
firmed an age-related significant prevalence of senile 
osteoporosis in men as well (21-25). 
Although several studies have already highlight-
ed higher mortality rates in women who experienced 
a vertebral fracture, the social and economic burden 
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of osteoporosis still remains partially underestimated 
(26-30). 
Identify bone weakening with an appropriate and 
accurate use of diagnostic imaging is of critical im-
portance in the diagnosis of osteoporosis at an early 
and in the management of the complications that of-
ten implicate differential diagnosis issues, most of all 
in a geriatric patient. It also allows to predict fracture 
risk, to determine the treatment approach and to help 
monitor disease progression and response to therapy. 
Therefore, the aim of this review is to evaluate the 
detection rates of the different imaging modalities in 
the evaluation of bone strength, in the fracture risk’s 
assessment and in the fragility fractures management.
Imaging techniques
Besides conventional radiography, imaging tech-
niques developed to diagnose the loss of bone mass and 
the micro architectural deterioration of bone tissue are 
dual-energy x-ray absorptiometry (DXA), quantita-
tive computed tomography (QCT), and quantitative 
ultrasound (QUS) (31-35). Generations of DXA sys-
tems provide not only accurate and reproducible meas-
urements of BMD but also the opportunity to use 
high-quality DXA scans in place of standard X-rays 
to identify vertebral fractures. Semiquantitative and 
fully quantitative methods to determine the presence 
of vertebral fracture (36), as well as indices related to 
hip geometry (35, 37-40), can be derived from high-
quality DXA images. Bone stiffness assessed by finite 
element analysis of X-ray images (FEXI), a technique 
that uses a finite element analysis model applied to 2D 
gray-level images, can also be extracted from DXA im-
ages (41-45).
Finally, the evaluation of bone mineral distribu-
tion at the proximal femur in hip DXA scans may be 
well suited to enhance standard densitometric evalu-
ations as a predictor of hip fracture risk.Taking ad-
vantage of high-quality DXA images, and based upon 
previous studies using 2D X-ray images to estimate 
bone microarchitecture, the trabecular bone score 
(TBS) was developed as another approach for assess-
ing skeletal microstructure noninvasively from 2D 
DXA projection images.
Dual Energy X-Ray Absorptiometry (DXA)
Dual energy X-ray Absorptiometry (DXA) is the 
most widely used quantitative technique for bone min-
eral density (BMD) assessment in clinical practice and 
represents the “gold standard” for a non-invasive diag-
nosis of osteoporosis, according to the World Health 
Organization (WHO) guidelines (46). 
BMD, measured in mg/cm3, is determined by 
peak bone mass and amount of bone loss, whereas bone 
quality refers to architecture, turnover, damage accu-
mulation (eg, micro fractures), and mineralization (47). 
BMD is defined using the T-score, which is the 
number of standard deviations (SD) above or below 
the mean for a healthy 30 y.o. adult of the same eth-
nicity and sex (which refers to the peak bone mass). 
The World Health Organization (WHO) has defined 
T-score threshold levels for BMD assessment: ≥-1.0 is 
considered as normal, values between ≤-1.0 and ≥-2.5 
refer to osteopenia, and a T-score ≤-2.5 is classified as 
osteoporosis. 
Z-score is the number of SD above or below the 
normal values of a healthy subject of the same age, sex, 
weight and ethnicity; this parameter is mostly used in 
the assessment of metabolic bone status of children 
and people aged over 75, but it should be also consid-
ered in women prior to menopause and men younger 
than 50 y.o. (7). A Z-score of −2.0 or lower is defined 
as “below the expected range for age” and a Z-score 
above −2.0 is “within the expected range for age” (1).
This definitions of osteopenia and osteoporosis only 
refer to DXA measurements at the lumbar spine (from 
L1 to L4, in antero-posterior projection), the proxi-
mal femur (neck and total femur as Region Of Interest 
-ROI) or the distal radius (1/3 distal radius as ROI).
Lumbar spine is the primary site for BMD meas-
urement. The BMD of proximal femur is the best predic-
tor of hip fracture. ROIs include femoral neck, trochant-
er, Ward’s area, intertrochanteric region, and total hip. 
The forearm is a third site used for BMD meas-
urement, useful when spine and hip are not measurable 
or interpretable due to severe degenerative processes, 
and implantable devices.
The advantages of DXA are short scan times, low 
radiation dose, good reproducibility, low cost, and wide 
availability. 
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This technique has some limitations, especially 
in the elderly, because spinal degeneration (most of 
all marginal osteophytes), spinal deformity, extreme 
obesity and abdominal aortic calcification may over-
estimate BMD and reduce the sensitivity of DXA 
for assessing osteoporosis. Furthermore DXA, being 
a two-dimensional measurement, cannot distinguish 
between cortical and trabecular bone (48).
Schneider et al. recommended the use of DXA 
of the hip for identification of osteoporosis in women 
aged 65 years and older who are likely to have spinal 
osteoarthritis (49) (Figure 1a - 1b).
The recent implementation of software for ad-
vanced hip assessment into DXA systems have pro-
vided a noninvasive description of the structural 
geometry of the proximal femur, depicting several pa-
rameters such as cortical thickness with bone mapping, 
areal BMD, hip axis length, cross-sectional area, cross-
sectional moment of inertia, and the femoral strength 
index (32, 50-53).
Trabecular Bone Score (TBS)
Although BMD measured by DXA is a major 
determinant of bone strength and fracture risk, most 
individuals with a fragility fracture will have BMD 
values in the osteopenic or even normal range (50). In 
addition to low bone mass, micro architectural deterio-
ration of bone tissue can lead to increased bone fragil-
ity and consequent increased risk of fracture. 
The evolution of DXA technology has allowed 
more advanced tools in the assessment of the bone sta-
tus with the aim to provide bone quality properties unre-
lated from BMD (54). The trabecular bone score (TBS) 
evaluates in DXA images of the lumbar spine (L1-L4) 
pixel grey-level variations, which have been associated 
to bone micro-architecture (55). An elevated TBS value 
correlates with better skeletal microstructure; a low TBS 
value correlates with weaker skeletal microstructure. 
TBS has the potential to discern differences be-
tween DXA scans that show similar BMD measure-
Figure 1a. Example of lumbar spine DXA of a 65 y.o. woman showing normal BMD values in mg/cm3 with the corresponding T-
score and Z-score
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ments. Since most individuals with fragility fractures 
may have BMD values in the range of normality or 
osteopenia, TBS could be useful to select patients to 
be screened and managed for osteoporosis (34, 56, 
57).
Several preliminary studies in patients affected 
by metabolic bone diseases have suggested that lum-
bar spine TBS, in addition to BMD and clinical risk 
factors, could be an important tool in the diagnosis 
of osteoporosis and especially in fracture risk assess-
ment.  
Despite these promising results, opinions in liter-
ature are still controversial and further normative data, 
validation and prospective studies are required (31).
Quantitative Computed Tomography (QCT) 
Unlike the DXA, which only measures density/
area in g/cm2, Quantitative Computed Tomography 
(QCT) allows true volumetric mineral density meas-
urements in mg/cm3. QCT also provides separate esti-
mation of trabecular and cortical BMD. 
The major advantage of QCT over DXA is the se-
lective measure of trabecular tissue, because trabecular 
bone is the main determinant of compressive strength 
in the vertebrae and purely trabecular bone measure is 
more sensitive to monitoring changes with disease and 
therapy (58, 59). 
To perform quantitative CT is used a standard 
CT scanner and phantom which acts as bone mineral 
reference standard to calibrate each scan. Density val-
ues measured in Hounsfield units are transformed into 
BMD measured in milligrams hydroxyapatite per cu-
bic centimeter by using a phantom. 
Typically QCT is performed at the spinal vertebrae 
(T12 to L4): ROIs are positioned in the trabecular por-
tion of the vertebral body, compared to the calibration 
phantom. The obtained vertebral densities are averaged 
and compared to those of a gender- and race-specific 
normal population (51, 60). The results are usually ex-
pressed in absolute values and as Z-scores and T-scores. 
Figure 1b. Example of hip DXA of the same 65 y.o. woman showing osteopenic BMD values in mg/cm3 with the corresponding 
T-score and Z-score
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Despite QCT has shown an excellent ability to 
predict vertebral fractures and a good sensitivity for 
BMD changes during the follow-up (61), it has some 
limitations that have narrowed its clinical diffusion: 
marrow change processes can affect trabecular meas-
urements, such as myelofibrosis, and the technique has 
higher radiation doses and costs compared to DXA.  
Currently, to obviate the limitations of DXA and 
axial QCT, is more frequently used a volumetric QCT 
(vQCT), which provides separate assessment of corti-
cal and trabecular bone at appendicular sites (62). The 
evolution of post-processing software allowed further 
analysis on bone geometrical and torsional stability, 
which correlates to bone strength and consequent sus-
ceptibility to fracture (63, 64).
Recommendations in clinical routine to charac-
terize fracture risk with the absolute measurements of 
volumetric BMD are: 110-80 mg/cm3 = mild increase 
in fracture risk; 80-50 mg/cm3 = moderate increase in 
fracture risk; <50 mg/cm3 = severe increase in fracture 
risk (65, 66).
High resolution quantitative computed tomog-
raphy (HR-QCT) has been performed on metabolic 
bone disease patients with the aim of providing a de-
tailed assessment of both cortical and trabecular archi-
tecture (67).With an 80-100 μm resolution, HR-QCT 
can measure (in addition to the parameters classically 
measured by QCT) bone volume fraction as well as 
cortical and trabecular parameters including thickness, 
separation, and number of trabeculae (68-71). Never-
theless, high costs and the expertise level required to 
handle these techniques has limited their application 
to few research centers.
Vertebral Morphometry 
Vertebral body fractures (VBF) are the most fre-
quent type of osteoporotic fractures, and they occur 
significantly earlier compared with wrist and hip frac-
tures (72-75). After sustaining an osteoporotic frac-
ture, patients are at a 50-100% greater risk of suffering 
another osteoporotic fracture. For this reason identify 
and treat patients with newly developed VBF is es-
sential to prevent further and more severe osteoporotic 
fractures, such as the hip fractures that leads to per-
sisting disabilities, hospitalization and operation costs 
(44, 76-78). 
Current DXA systems allow to use high quality 
DXA scans instead of standard X-rays to identify ver-
tebral fractures. Radiographic diagnosis with conven-
tional lateral radiographs of the thoracolumbar spine 
is considered to be the best way to identify and con-
firm the presence of osteoporotic vertebral fractures in 
clinical practice. The two most widely used methods 
to determine the severity of such fractures in clinical 
research are the semi quantitative assessment of ver-
tebral deformities, which is based on visual evaluation, 
and the quantitative approach, which is based on dif-
ferent morphometric criteria (79). 
The morphological classification (wedge, bicon-
cave, crush) of VBF results from more than 20% loss in 
anterior, middle or posterior heights of vertebral bod-
ies. VBFs are also classified as mild (20–25%), moderate 
(26-40%), and severe (>40%) reductions in any height.
The visual semi-quantitative approach proposed 
by Genant et al. (79) has been integrated with mor-
phometric methods based on vertebral height meas-
urements. The quantitative vertebral morphometry can 
be applied on spinal radiographs (MXR: Morphomet-
ric X-ray Radiography) or on DXA images (MXA: 
Morphometric X-ray Absorptiometry). 
Several semi-automated software have been intro-
duced with the aim of digitize and automatize MRX, 
improving its reproducibility (80). The operator has to 
manually identify the vertebral levels (from T5 to L4) 
then a semi-automated six-points segmentation of the 
vertebrae calculates the vertebral heights (posterior - 
Hp, middle - Hm and anterior Ha) and the ratio be-
tween heights (Ha/Hp, Hm/Hp) of each vertebra. The 
last step of the analysis includes the report of fracture 
assessment based on normative data and models (81). 
The widespread diffusion of DXA and the tech-
nical improvements have allowed the application of 
quantitative morphometry on lateral DXA images of 
the spine.  Thanks to its lower radiation exposure, MXA 
nowadays represents the most widely adopted solution 
for quantitative assessment of fracture status and has 
been fully integrated into DXA-based BMD assess-
ment of osteoporosis in clinical routine (82) (Figure 2).
However, the radiologist’s role still remains criti-
cal in order to distinguish osteoporotic vertebral frac-
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tures from malignancies and other congenital or ac-
quired deformities. 
Quantitative Ultrasound (QUS)
Quantitative Ultrasound (QUS) is a portable, 
radiation-free and low cost technique performed with 
dedicated scanners. It provides  measurements of 
quantitative parameters related to bone quality prop-
erties through the analysis of interactions between ul-
trasound and bone. It is usually performed to periph-
eral sites such as calcaneus (primary site), metaphysis 
of the phalanx, radius and tibia. Transit time velocity 
and ultrasound attenuation represent the most widely 
adopted parameters: velocity decreases in osteoporo-
tic bone, whereas ultrasound attenuation increases in 
osteoporotic bone. QUS results can be expressed in 
absolute values or in T-score and Z-score linked to 
normative reference data (66, 83-86). 
Several studies have shown that QUS parameters 
can differentiate individuals with from those without 
fragility fractures and are predictive of osteoporotic 
fractures (87-89). However, despite quantitative US 
can be useful as screening tool for the estimation of 
fracture risk, the WHO has stated that it cannot be 
used as stand-alone tool for the diagnosis of osteopo-
rosis and and to monitor treatment response (90).
RM Imaging
The concept of bone strength as result of bone 
quantity and bone quality have induced the scientific 
community to explore other imaging modalities capa-
ble of obtaining micro-architectural data of trabecular 
bone with the aim to understand the relationship be-
tween bone turnover, density and architecture (47).
Several studies have explored MR’s ability to cor-
relate trabecular content and architecture with bone 
Figure 2. Example of quantitative morphometry on lateral DXA images of the spine, showing several vertebral body fractures (VBF), 
with the corresponding fracture classification in mild (type1), moderate (type2), and severe (type 3)
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turnover (45, 91-94). The technique has been mainly 
established for peripheral imaging of the distal radius, 
tibia, and calcaneus.
Specific high resolution sequences and imaging 
analysis algorithms have been developed to obtain a 
non-invasive assessment of bone strength and turnover 
(95). 
Bone marrow is critical to the viability and 
strength of trabecular and cortical bone.
Dynamic contrast-enhanced MR imaging (DCE-
MRI) studies across different age groups have revealed 
that vertebral marrow perfusion is reduced in elderly 
and in patients with osteoporosis compared to subjects 
with osteopenia (96, 97). 
Subjects with osteoporosis or osteopenia revealed 
a significantly increased marrow fat content compared 
with the fat content in subjects with normal bone den-
sity. The concomitant observation that both adipocytes 
and osteoblasts arise from common precursor cells has 
suggested the hypothesis that preferential differentia-
tion of mesenchymal stem cells towards the adipocyte 
lineage may negatively influence osteoblast differentia-
tion (98, 99).
Proton RM spectroscopy (MRS) has been pro-
posed as a promising candidate into routine clinical 
procedures for quantifying marrow adiposity non-
invasively. MRS-based studies have revealed an age-
dependent linear increase in vertebral marrow fat con-
tent at various skeletal sites (100, 101). In contrast to 
the qualitative evaluation of red marrow versus yellow 
marrow provided by conventional MR imaging, MR 
spectroscopy provides quantitative assessment of water 
and fat content in bone marrow (102). 
Conclusions
Osteoporosis is a major worldwide health prob-
lem, which contribute to reduce physical performance 
and increase the risk of fall-related injury, disability, 
and mortality in aging people (103). Without preven-
tion and screening, osteoporosis may be clinically si-
lent with an increased incidence of osteoporotic frac-
tures and consequently with an exponentially grow of 
the socio-economic costs associated to osteoporotic 
fracture-related morbidity and mortality. 
Therefore, early diagnosis of osteoporosis and ad-
equate management of its complications are becoming 
a particularly relevant concern in the context of guar-
antee a true “healthy aging”. 
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